Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion

Detalles Bibliográficos
Autores principales: Decool, Gauthier, Domenech, Carine, Grardel, Nathalie, Plesa, Adriana, Raczkiewicz, Imelda, Ducourneau, Benoit, Ruminy, Philippe, Pages, Marie-Pierre, Girard, Sandrine, Fenwarth, Laurène, Preudhomme, Claude, Bertrand, Yves, Duployez, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746024/
https://www.ncbi.nlm.nih.gov/pubmed/31723830
http://dx.doi.org/10.1097/HS9.0000000000000193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746024/
https://www.ncbi.nlm.nih.gov/pubmed/31723830
http://dx.doi.org/10.1097/HS9.0000000000000193

Ejemplares similares